These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 12742556

  • 21. Comparison of spironolactone-oral contraceptive versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
    Erenus M, Yücelten D, Gürbüz O, Durmuşoğlu F, Pekin S.
    Fertil Steril; 1996 Aug; 66(2):216-9. PubMed ID: 8690104
    [Abstract] [Full Text] [Related]

  • 22. Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives.
    Mastorakos G, Koliopoulos C, Creatsas G.
    Fertil Steril; 2002 May; 77(5):919-27. PubMed ID: 12009344
    [Abstract] [Full Text] [Related]

  • 23. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
    Godsland IF, Crook D, Devenport M, Wynn V.
    Contraception; 1995 Sep; 52(3):143-9. PubMed ID: 7587185
    [Abstract] [Full Text] [Related]

  • 24. Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel.
    Hammond GL, Langley MS, Robinson PA, Nummi S, Lund L.
    Fertil Steril; 1984 Jul; 42(1):44-51. PubMed ID: 6233179
    [Abstract] [Full Text] [Related]

  • 25. Serum prostate specific antigen levels in women with polycystic ovary syndrome and the effect of flutamide+desogestrel/ethinyl estradiol combination.
    Bahceci M, Bilge M, Tuzcu A, Tuzcu S, Bahceci S.
    J Endocrinol Invest; 2004 Apr; 27(4):353-6. PubMed ID: 15233555
    [Abstract] [Full Text] [Related]

  • 26. Gonadotropin-releasing hormone analog plus an oral contraceptive containing desogestrel in women with severe hirsutism: effects on hair, bone, and hormone profile after 1-year use.
    Castelo-Branco C, Martínez de Osaba MJ, Pons F, Fortuny A.
    Metabolism; 1997 Apr; 46(4):437-40. PubMed ID: 9109850
    [Abstract] [Full Text] [Related]

  • 27. Changes in blood levels of proteinase inhibitors, pregnancy zone protein, steroid carriers and complement factors induced by oral contraceptives.
    Nielsen CH, Poulsen HK, Teisner B, Thorsen P, Hau J, Westergaard JG.
    Eur J Obstet Gynecol Reprod Biol; 1993 Sep; 51(1):63-71. PubMed ID: 7506680
    [Abstract] [Full Text] [Related]

  • 28. Desogestrel+ethinylestradiol versus levonorgestrel+ethinylestradiol. Which one has better affect on acne, hirsutism, and weight change.
    Sanam M, Ziba O.
    Saudi Med J; 2011 Jan; 32(1):23-6. PubMed ID: 21212911
    [Abstract] [Full Text] [Related]

  • 29. A randomized controlled trial of second- versus third-generation oral contraceptives in the treatment of acne vulgaris.
    Rosen MP, Breitkopf DM, Nagamani M.
    Am J Obstet Gynecol; 2003 May; 188(5):1158-60. PubMed ID: 12748463
    [Abstract] [Full Text] [Related]

  • 30. Ovarian activity suppression by two different low-dose triphasic oral contraceptives.
    van der Does J, Exalto N, Dieben T, Bennink HC.
    Contraception; 1995 Dec; 52(6):357-61. PubMed ID: 8749599
    [Abstract] [Full Text] [Related]

  • 31. The effect of an oral contraceptive containing ethinylestradiol and desogestrel on hair growth and hormonal parameters of hirsute women.
    Ruutiainen K.
    Int J Gynaecol Obstet; 1986 Oct; 24(5):361-8. PubMed ID: 2880770
    [Abstract] [Full Text] [Related]

  • 32. Protein binding of active ingredients and comparison of serum ethinyl estradiol, sex hormone-binding globulin, corticosteroid-binding globulin, and cortisol levels in women using a combination of gestodene/ethinyl estradiol (Femovan) or a combination of desogestrel/ethinyl estradiol (Marvelon) and single-dose ethinyl estradiol bioequivalence from both oral contraceptives.
    Hümpel M, Täuber U, Kuhnz W, Pfeffer M, Brill K, Heithecker R, Louton T, Steinberg B, Seifert W, Schütt B.
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):329-33. PubMed ID: 2142574
    [Abstract] [Full Text] [Related]

  • 33. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women.
    Lewis MA, Heinemann LA, Spitzer WO, MacRae KD, Bruppacher R.
    Contraception; 1997 Sep; 56(3):129-40. PubMed ID: 9347202
    [Abstract] [Full Text] [Related]

  • 34. Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins.
    Wiegratz I, Jung-Hoffmann C, Kuhl H.
    Contraception; 1995 Jun; 51(6):341-6. PubMed ID: 7554973
    [Abstract] [Full Text] [Related]

  • 35. Pharmacokinetics of a triphasic oral contraceptive containing desogestrel and ethinyl estradiol.
    Archer DF, Timmer CJ, Lammers P.
    Fertil Steril; 1994 Apr; 61(4):645-51. PubMed ID: 8150105
    [Abstract] [Full Text] [Related]

  • 36. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
    Kemmeren JM, Algra A, Meijers JC, Bouma BN, Grobbee DE.
    Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
    [Abstract] [Full Text] [Related]

  • 37. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD, Lawrenson RA, Thompson CR, Kennedy JG, Hambleton IR.
    Lancet; 1997 Jan 11; 349(9045):83-8. PubMed ID: 8996419
    [Abstract] [Full Text] [Related]

  • 38. Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study.
    Carr BR, Breslau NA, Givens C, Byrd W, Barnett-Hamm C, Marshburn PB.
    J Clin Endocrinol Metab; 1995 Apr 11; 80(4):1169-78. PubMed ID: 7714086
    [Abstract] [Full Text] [Related]

  • 39. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris.
    Lucky AW, Henderson TA, Olson WH, Robisch DM, Lebwohl M, Swinyer LJ.
    J Am Acad Dermatol; 1997 Nov 11; 37(5 Pt 1):746-54. PubMed ID: 9366821
    [Abstract] [Full Text] [Related]

  • 40. Short-term treatment of hirsutism related to micropolycystic ovary syndrome with a combination type oral contraceptive containing desogestrel.
    Sobbrio GA, Granata A, D'Arrigo F, Arena D, Trimarchi F, Granese D, Pullè C.
    Acta Eur Fertil; 1989 Nov 11; 20(1):35-7. PubMed ID: 2528880
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.